Evidence map›Paper›PMID 26247583›Full record

ArticleJournal of neurotrauma2016

Dietary Docosahexaenoic Acid Improves Cognitive Function, Tissue Sparing, and Magnetic Resonance Imaging Indices of Edema and White Matter Injury in the Immature Rat after Traumatic Brain Injury.

Michelle E Schober, Daniela F Requena, Osama M Abdullah, T Charles Casper, Joanna Beachy, Daniel Malleske, James R Pauly

Open access · greenAbstract read
In one paragraph

Article in Journal of neurotrauma, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Observational
  11. Antioxidant Therapies in Traumatic Brain Injury.Antioxidants (Basel, Switzerland) · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Nutrition practices and knowledge among NCAA Division III football players.Journal of the International Society of Sports Nutrition · 2017
    Article
  19. Article
  20. Diffusion Imaging of White Matter In Schizophrenia: Progress and Future Directions.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Michelle E Schober1 Department of Pediatrics, Division of Critical Care, University of Utah , Salt Lake City, Utah.
Daniela F Requena1 Department of Pediatrics, Division of Critical Care, University of Utah , Salt Lake City, Utah.
Osama M Abdullah2 Department of Bioengineering, University of Utah , Salt Lake City, Utah.
T Charles Casper1 Department of Pediatrics, Division of Critical Care, University of Utah , Salt Lake City, Utah.
Joanna Beachy3 Department of Pediatrics, Division of Neonatology, University of Utah , Salt Lake City, Utah.
Daniel Malleske3 Department of Pediatrics, Division of Neonatology, University of Utah , Salt Lake City, Utah.
James R Pauly4 College of Pharmacy and Spinal Cord and Brain Injury Research Center, University of Kentucky , Lexington, Kentucky.
University of Utah · US

Funding

Mechanisms of Docosahexaenoic Acid Neuroprotection after Rat Pup TBIR21NS090098 · NINDS · UNIVERSITY OF UTAH · PI SCHOBER, MICHELLE ELENA · 2015 to 2016
$423k
NINDS NIH HHS R21 NS090098
6 · The paper itself

Abstract

Traumatic brain injury (TBI) is the leading cause of acquired neurologic disability in children. Specific therapies to treat acute TBI are lacking. Cognitive impairment from TBI may be blunted by decreasing inflammation and oxidative damage after injury. Docosahexaenoic acid (DHA) decreases cognitive impairment, oxidative stress, and white matter injury in adult rats after TBI. Effects of DHA on cognitive outcome, oxidative stress, and white matter injury in the developing rat after experimental TBI are unknown. We hypothesized that DHA would decrease early inflammatory markers and oxidative stress, and improve cognitive, imaging and histologic outcomes in rat pups after controlled cortical impact (CCI). CCI or sham surgery was delivered to 17 d old male rat pups exposed to DHA or standard diet for the duration of the experiments. DHA was introduced into the dam diet the day before CCI to allow timely DHA delivery to the pre-weanling pups. Inflammatory cytokines and nitrates/nitrites were measured in the injured brains at post-injury Day (PID) 1 and PID2. Morris water maze (MWM) testing was performed at PID41-PID47. T2-weighted and diffusion tensor imaging studies were obtained at PID12 and PID28. Tissue sparing was calculated histologically at PID3 and PID50. DHA did not adversely affect rat survival or weight gain. DHA acutely decreased oxidative stress and increased anti-inflammatory interleukin 10 in CCI brains. DHA improved MWM performance and lesion volume late after injury. At PID12, DHA decreased T2-imaging measures of cerebral edema and decreased radial diffusivity, an index of white matter injury. DHA improved short- and long-term neurologic outcomes after CCI in the rat pup. Given its favorable safety profile, DHA is a promising candidate therapy for pediatric TBI. Further studies are needed to explore neuroprotective mechanisms of DHA after developmental TBI.

Indexed as

Diffusion Tensor ImagingAnimalsBrain EdemaBrain Injuries, TraumaticCognitive DysfunctionDocosahexaenoic AcidsMaleMaze LearningRatsRats, Sprague-DawleyWhite MatterDocosahexaenoic Acidscontrolled cortical impactDTIMorris water mazepediatric

Identifiers

PMID26247583
PMCPMC4761828
OpenAlexW1955003571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.